Fresenius Medical Care AG (FMS): Price and Financial Metrics


Fresenius Medical Care AG (FMS): $38.42

-0.90 (-2.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

FMS POWR Grades


  • FMS scores best on the Stability dimension, with a Stability rank ahead of 99.21% of US stocks.
  • FMS's strongest trending metric is Growth; it's been moving down over the last 31 weeks.
  • FMS ranks lowest in Growth; there it ranks in the 24th percentile.

FMS Stock Summary

  • With a market capitalization of $23,992,448,614, Fresenius Medical Care AG & Co KGaA has a greater market value than 89.77% of US stocks.
  • With a year-over-year growth in debt of 66.23%, Fresenius Medical Care AG & Co KGaA's debt growth rate surpasses 88.14% of about US stocks.
  • The volatility of Fresenius Medical Care AG & Co KGaA's share price is greater than that of merely 7.87% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Fresenius Medical Care AG & Co KGaA, a group of peers worth examining would be WAB, IEX, HRL, IP, and HIG.
  • FMS's SEC filings can be seen here. And to visit Fresenius Medical Care AG & Co KGaA's official web site, go to www.freseniusmedicalcare.com.

FMS Valuation Summary

  • FMS's EV/EBIT ratio is 17; this is 36.33% lower than that of the median Healthcare stock.
  • FMS's price/sales ratio has moved up 0.9 over the prior 243 months.
  • FMS's EV/EBIT ratio has moved up 7.9 over the prior 243 months.

Below are key valuation metrics over time for FMS.

Stock Date P/S P/B P/E EV/EBIT
FMS 2021-04-05 1.2 1.9 18.6 15.9
FMS 2020-07-14 1.4 2.1 21.0 18.1
FMS 2018-06-05 1.7 3.2 24.2 17.6
FMS 2010-03-10 1.4 2.4 18.0 12.5
FMS 2009-06-18 1.2 2.2 15.9 11.1
FMS 2002-12-05 0.2 0.4 3.6 7.5

FMS Growth Metrics

  • Its 4 year price growth rate is now at -16.51%.
  • The 3 year price growth rate now stands at -0.19%.
  • Its 3 year revenue growth rate is now at -2.42%.
FMS's revenue has moved up $1,121,481,000 over the prior 61 months.

The table below shows FMS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2020-12-31 17,859.06 4,233.156 1,164.377
2019-12-31 17,476.56 2,566.951 1,199.619
2018-12-31 16,546.87 2,061.911 1,981.924
2018-12-31 16,546.87 2,061.911 1,981.924
2017-12-31 17,783.57 2,191.811 1,279.788
2016-12-31 17,910.79 2,139.882 1,243.267

FMS Stock Price Chart Interactive Chart >

Price chart for FMS

FMS Price/Volume Stats

Current price $38.42 52-week high $44.94
Prev. close $39.32 52-week low $33.84
Day low $38.08 Volume 460,245
Day high $38.57 Avg. volume 348,115
50-day MA $40.95 Dividend yield 1.45%
200-day MA $39.80 Market Cap 22.51B

Fresenius Medical Care AG (FMS) Company Bio


Fresenius Medical Care provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease, and other health care services. The company was founded in 1996 and is based in Bad Homburg, Germany.

FMS Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$38.42$302.6 635%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Fresenius Medical Care AG & Co KGaA. To summarize, we found that Fresenius Medical Care AG & Co KGaA ranked in the 87th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Fresenius Medical Care AG & Co KGaA, consider:

  • 49% of the company's capital comes from equity, which is greater than just 15.33% of stocks in our cash flow based forecasting set.
  • Fresenius Medical Care AG & Co KGaA's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 1.98% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Fresenius Medical Care AG & Co KGaA has a reliance on debt greater than 91.81% of them.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%620%
1%627%
2%635%
3%642%
4%649%
5%656%

Want more companies with a valuation profile/forecast similar to that of Fresenius Medical Care AG & Co KGaA? See SXTC, FGEN, GTS, ASNB, and EBS.


FMS Latest News Stream


Event/Time News Detail
Loading, please wait...

FMS Latest Social Stream


Loading social stream, please wait...

View Full FMS Social Stream

Latest FMS News From Around the Web

Below are the latest news stories about Fresenius Medical Care AG & Co KGaA that investors may wish to consider to help them evaluate FMS as an investment opportunity.

German shares lose 0.61 pct Friday

FRANKFURT, July 30 (Xinhua) -- German shares lost on Friday, with the benchmark DAX index down 96.08 points, or 0.61 percent, to close at 15,544.39 points. Renal dialysis equipment supplier Fresenius Medical lost the most among the blue chips, down by 4.53 percent, followed by European health care company Fresenius SE and Deutsche Post, which lost 3.93 percent and 2.11 percent respectively. Multinational

Big News Network | July 30, 2021

ExThera Medical Corporation: ExThera Expands Distribution of Blood Purification and Pathogen Reduction Treatment for Sepsis and COVID-19 in Europe

ExThera Medical and Fresenius Medical Care to offer Seraph 100 Microbind Affinity Filter in Turkey, Finland, and Estonia ExThera Medical, maker of the only effective pathogen-removal, hemoperfusio

FinanzNachrichten | July 28, 2021

Clinical Diagnostics Devices Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Medtronic Inc, Boston Scientific, Fresenius Medical Care AG & Co. KGAA, Siemens AG,

This report studies the Clinical Diagnostics Devices Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Clinical Diagnostics Devices market segmented by company, []

Jumbo News | July 22, 2021

Plasma Component Separator Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:B Braun Melsungen, Haemonetics, Fresenius Medical Care, Toray Medical, Terumo, Kawasu

This report studies the Plasma Component Separator Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Plasma Component Separator market segmented by company, []

Jumbo News | July 22, 2021

UPS Healthcare Announces Agreement With Fresenius Medical Care, Expanding Service In The UK

LONDON and BAD HOMBURG, Germany, July 22, 2021 /PRNewswire/ -- UPS Healthcare''s UK operation, Polar Speed, today announced a five-year commercial agreement with Fresenius Medical Care, a leading i

FinanzNachrichten | July 22, 2021

Read More 'FMS' Stories Here

FMS Price Returns

1-mo -6.11%
3-mo -2.72%
6-mo 12.48%
1-year -10.10%
3-year -20.24%
5-year -11.42%
YTD -6.25%
2020 14.17%
2019 15.01%
2018 -37.85%
2017 25.49%
2016 1.62%

FMS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full FMS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.0349 seconds.